Research & Analysis

Johnson & Johnson (J&J) has been in China for over 30 years, predating the country’s economic opening in 1979.The company entered China through a technology-transfer agreement to build a chemical factory in 1979. In 1985, J&J established its first joint venture in China, Xi’an-Janssen Pharmaceutical Ltd., and it is now beginning to retire its first […]

Foreign investors in China’s healthcare sector must work hard to reach their target clientele—China’s increasingly affluent middle class. by James Glucksman and Roberta Lipson The healthcare reforms that the PRC government announced in early 2009 have elicited considerable excitement among potential investors in China’s large and growing healthcare services market. The reforms will boost healthcare […]

Drug companies must be able to navigate the procurement bidding process to successfully reach China’s market.by Chen Yang and Lei LiState-run, nonprofit healthcare institutions in China procure most of the drugs they use through a bidding process centralized at the provincial level. This means that healthcare institutions must purchase a large share of the drugs […]

China’s new drug lists and associated pricing rules aim to provide low-cost drugs to patients but raise questions about the impact on hospitals and drug manufacturers.by Gordon Schatz and Patrick NowlinAnyone who has visited the Dongyue Daoist Temple in Beijing knows that this temple reflects key societal values that date back 600 years or more. […]

More government investment will create new opportunities for medical device suppliers, but producers must be patient and creative to overcome obstacles.by Judy ZakreskiDevelopments in China’s domestic policies—particularly its massive healthcare reform effort and stimulus spending to offset the global economic downturn—have cast a spotlight on its medical device market. Exactly how China’s stimulus programs may […]

A delegation of the US-China Business Council’s (USCBC) board of directors visited Beijing for meetings with the PRC government on November 4-5. USCBC Chair Andrew Liveris of the Dow Chemical Co. led the delegation, which included 10 other board directors and USCBC President John Frisbie. The delegation met with top leaders, including PRC Vice Premier […]

A behind-the-scenes look at transporting artifactsby Paula M. MillerAfter touring museums in California, Georgia, and Texas, an exhibition of 2,000-year-old terra cotta warriors from the tomb of China’s first emperor arrived at the National Geographic Museum in Washington, DC, in November 2009. Though many enthused museumgoers will line up, tickets in hand, to see the […]

Top PRC leaders set a cautiously optimistic tone for China’s 2010 economic development at the December 2009 Central Economic Work Conference, the most authoritative annual conference on China’s economy. The conference gathered China’s top central- and local-government leaders to discuss the past year and plan broad macroeconomic policies for 2010. As expected, the December meetings […]

by Barbara Li In the last few years, China has enacted important product safety laws and regulations. Companies doing business in—and with—China should acquaint themselves with these developments. Legislation China does not have a single, codified product safety law. Manufacturers and sellers of products and other stakeholders in this area must follow legal requirements as […]

The recent bilateral product safety summit brought the US-China dialogue to a new level, with both parties committing to a more comprehensive approach.by Michael J. WagnerThe US Consumer Product Safety Commission (CPSC) and the PRC Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) held the Third Biennial US-China Consumer Product Safety Summit in late October […]